These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3262991)
41. Involvement of PAF in postallergic propranolol-induced bronchoconstriction in guinea-pigs. Fujimura M; Tsujiura M; Songür N; Myou S; Matsuda T Eur Respir J; 1996 Oct; 9(10):2064-9. PubMed ID: 8902468 [TBL] [Abstract][Full Text] [Related]
42. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530 [TBL] [Abstract][Full Text] [Related]
43. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs. Sakuma Y; Tsunoda H; Shirato M; Katayama S; Yamatsu I; Katayama K Prostaglandins; 1991 Nov; 42(5):463-72. PubMed ID: 1763202 [TBL] [Abstract][Full Text] [Related]
44. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
45. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Casals-Stenzel J Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490 [TBL] [Abstract][Full Text] [Related]
46. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related]
47. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs. Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014 [TBL] [Abstract][Full Text] [Related]
48. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma]. Arima M; Yukawa T; Terashi Y; Sagara H; Makino S Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. Touvay C; Etienne A; Braquet P Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380 [TBL] [Abstract][Full Text] [Related]
51. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation. Tsunoda H; Sakuma Y; Shirato M; Obaishi H; Harada K; Yamada K; Shimomura N; Machida Y; Yamatsu I; Katayama K Arzneimittelforschung; 1991 Mar; 41(3):224-7. PubMed ID: 1867658 [TBL] [Abstract][Full Text] [Related]
52. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs]. Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119 [TBL] [Abstract][Full Text] [Related]
53. Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig. Lagente V; Desquand S; Hadvary P; Cirino M; Lellouch-Tubiana A; Lefort J; Vargaftig BB Br J Pharmacol; 1988 May; 94(1):27-36. PubMed ID: 3401641 [TBL] [Abstract][Full Text] [Related]
54. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig. Regal JF; Fraser DG; Toth CA J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173 [TBL] [Abstract][Full Text] [Related]
55. [Interference of platelet-activating factor antagonist, BN50739 with the releasing of inflammatory mediators from anaphylactic lung of guinea pig]. Zhang JN Zhonghua Jie He He Hu Xi Za Zhi; 1992 Dec; 15(6):347-8, 380. PubMed ID: 1339617 [TBL] [Abstract][Full Text] [Related]
56. Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224. Gulbenkian AR; Fernandez X; Kreutner W; Minnicozzi M; Watnick AS; Kung T; Egan RW Am Rev Respir Dis; 1990 Sep; 142(3):680-5. PubMed ID: 2117872 [TBL] [Abstract][Full Text] [Related]
57. Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. Herbert JM; Lespy L; Maffrand JP Eur J Pharmacol; 1991 Dec; 205(3):271-6. PubMed ID: 1817964 [TBL] [Abstract][Full Text] [Related]
58. Inhibitory effect of NZ-107 on anaphylactic bronchoconstriction in guinea pigs and rats. Iwama T; Shikada K; Yamamoto A; Sakashita M; Hibi M; Tanaka S Int Arch Allergy Immunol; 1992; 97(2):99-104. PubMed ID: 1582710 [TBL] [Abstract][Full Text] [Related]